COVD-18. POTENTIAL TO HARNESS SARS-COV-2 NEUROTROPISM IN THE DELIVERY OF ONCOLYTIC VIROTHERAPY FOR THE TREATMENT OF HIGH-GRADE GLIOMA

BACKGROUND: High-grade gliomas (HGG) pose therapeutic challenges stemming from blood brain barrier, infiltrative growth, suppressed immune function, and tumor heterogeneity. Oncolytic viruses (OVs) are gaining traction for addressing these challenges. There is evidence that the SARS-CoV-2 glycoprote...

Descripción completa

Detalles Bibliográficos
Autores principales: Immidisetti, Amanda, Munier, Sean, Patel, Nitesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Covid-19 and Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650446/
http://dx.doi.org/10.1093/neuonc/noaa215.101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650446/
http://dx.doi.org/10.1093/neuonc/noaa215.101

Ejemplares similares